Evaluation of Patients With Cognitive Impairment Due to Suspected Idiopathic Normal-Pressure Hydrocephalus at Medical Centers for Dementia: A Nationwide Hospital-Based Survey in Japan

Objective Treatment of idiopathic normal-pressure hydrocephalus (iNPH) requires collaboration between dementia specialists and neurosurgeons. The role of dementia specialists is to differentiate patients with iNPH from patients with other dementia diseases and to determine if other dementia diseases are comorbid with iNPH. We conducted a nationwide hospital-based questionnaire survey on iNPH in medical centers for dementia (MCDs). Methods We developed a questionnaire to assess how physicians in MCDs evaluate and treat patients with cognitive impairment due to suspected iNPH and the difficulties these physicians experience in the evaluation and treatment of patients. The questionnaire was sent to all 456 MCDs in Japan. Results Questionnaires from 279 MCDs were returned to us (response rate: 61.2%). Patients underwent cognitive tests, evaluation of the triad symptoms of iNPH, and morphological neuroimaging examinations in 96.8, 77.8, and 98.2% of the MCDs, respectively. Patients with suspected iNPH were referred to other hospitals (e.g., hospitals with neurosurgery departments) from 78.9% of MCDs, and cerebrospinal fluid (CSF) tap test was performed in 44 MCDs (15.8%). iNPH guidelines (iNPHGLs) and disproportionately enlarged subarachnoid space hydrocephalus (DESH), a specific morphological finding, were used and known in 39.4% and 38% of MCDs, respectively. Logistic regression analysis with “Refer the patient to other hospitals (e.g., hospitals with neurosurgery departments) when iNPH is suspected.” as the response variable and (a) using the iNPHGLs, (b) knowledge of DESH, (c) confidence regarding DESH, (d) difficulty with performing brain magnetic resonance imaging, (e) knowledge of the methods of CSF tap test, (f) absence of physician who can perform lumbar puncture, and (g) experience of being told by neurosurgeons that referred patients are not indicated for shunt surgery as explanatory variables revealed that the last two factors were significant predictors of patient referral from MCDs to other hospitals. Conclusion Sufficient differential or comorbid diagnosis using CSF tap test was performed in a few MCDs. Medical care for patients with iNPH in MCDs may be improved by having dementia specialists perform CSF tap tests and share the eligibility criteria for shunt surgery with neurosurgeons.

[1]  K. Blennow,et al.  Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients , 2022, Fluids and barriers of the CNS.

[2]  M. Hiltunen,et al.  Elevated CSF LRG and Decreased Alzheimer’s Disease Biomarkers in Idiopathic Normal Pressure Hydrocephalus , 2021, Journal of clinical medicine.

[3]  S. Aoki,et al.  Guidelines for Management of Idiopathic Normal Pressure Hydrocephalus (Third Edition): Endorsed by the Japanese Society of Normal Pressure Hydrocephalus , 2021, Neurologia medico-chirurgica.

[4]  F. Lundin,et al.  Optical Coherence Tomography Revealing Ganglion Cell Loss in idiopathic Normal Pressure Hydrocephalus. , 2021, World neurosurgery.

[5]  K. Blennow,et al.  Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease. , 2020, Journal of Alzheimer's disease : JAD.

[6]  I. Robertson,et al.  Incidence, diagnostic criteria and outcome following ventriculoperitoneal shunting of idiopathic normal pressure hydrocephalus in a memory clinic population: a prospective observational cross-sectional and cohort study , 2019, BMJ Open.

[7]  L. Churilov,et al.  Idiopathic Normal Pressure Hydrocephalus (Hakim-Adams Syndrome): Clinical Symptoms, Diagnosis and Treatment. , 2019, Psychiatria Danubina.

[8]  D. Kaya,et al.  The Outcomes Of Serial Cerebrospinal Fluid Removal In Elderly Patients With Idiopathic Normal Pressure Hydrocephalus , 2019, Clinical interventions in aging.

[9]  E. Larsson,et al.  Standardized image evaluation in patients with idiopathic normal pressure hydrocephalus: consistency and reproducibility , 2019, Neuroradiology.

[10]  K. Blennow,et al.  CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics , 2019, Journal of Neurology, Neurosurgery, and Psychiatry.

[11]  L. Söderström,et al.  Prevalence of idiopathic normal pressure hydrocephalus: A prospective, population-based study , 2019, PloS one.

[12]  S. Hasselbalch,et al.  Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus versus Alzheimer's Disease and Subcortical Ischemic Vascular Disease: A Systematic Review. , 2019, Journal of Alzheimer's disease : JAD.

[13]  H. Sugano,et al.  Preoperative Phosphorylated Tau Concentration in the Cerebrospinal Fluid Can Predict Cognitive Function Three Years after Shunt Surgery in Patients with Idiopathic Normal Pressure Hydrocephalus , 2018, Journal of Alzheimer's disease : JAD.

[14]  J. Suvisaari,et al.  Prevalence of Schizophrenia in Idiopathic Normal Pressure Hydrocephalus , 2018, Neurosurgery.

[15]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[16]  L. Söderström,et al.  Challenges in diagnosing normal pressure hydrocephalus: Evaluation of the diagnostic guidelines , 2017, eNeurologicalSci.

[17]  E. Mori,et al.  Clinical characteristics of idiopathic normal pressure hydrocephalus with Lewy body diseases , 2015, Journal of the Neurological Sciences.

[18]  K. Yoshiyama,et al.  [The Current Status of Medical Care for Idiopathic Normal-pressure Hydrocephalus in Medical Centers for Dementia in Japan]. , 2015, Brain and nerve = Shinkei kenkyu no shinpo.

[19]  E. Mori,et al.  Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial , 2015, The Lancet Neurology.

[20]  H. Sugano,et al.  Use of external lumbar cerebrospinal fluid drainage and lumboperitoneal shunts with Strata NSC valves in idiopathic normal pressure hydrocephalus: a single-center experience. , 2015, World neurosurgery.

[21]  E. Larsson,et al.  Preoperative Prognostic Value of MRI Findings in 108 Patients with Idiopathic Normal Pressure Hydrocephalus , 2014, American Journal of Neuroradiology.

[22]  K. Blennow,et al.  The cerebrospinal fluid “Alzheimer profile”: Easily said, but what does it mean? , 2014, Alzheimer's & Dementia.

[23]  H. Soininen,et al.  Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus , 2014, PloS one.

[24]  K. Ishii,et al.  Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery , 2013, Journal of the Neurological Sciences.

[25]  K. Ishii,et al.  Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. , 2012, Neurologia medico-chirurgica.

[26]  P. Hellström,et al.  One‐year outcome in the European multicentre study on iNPH , 2012, Acta neurologica Scandinavica.

[27]  Etsuro Mori,et al.  Diagnosis of idiopathic normal pressure hydrocephalus is supported by MRI-based scheme: a prospective cohort study , 2010, Cerebrospinal Fluid Research.

[28]  J. Trojanowski,et al.  Lack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology , 2010, Annals of neurology.

[29]  S. Awata MINI‐REVIEW: New national health program against dementia in Japan: The medical center for dementia , 2010, Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society.

[30]  M. Ishikawa,et al.  Neuropsychiatric Symptoms in Patients with Idiopathic Normal Pressure Hydrocephalus , 2009, Behavioural neurology.

[31]  M. Kivimäki,et al.  Does personality predict mortality? Results from the GAZEL French prospective cohort study. , 2007, International journal of epidemiology.

[32]  G. Waldemar,et al.  Idiopathic normal-pressure hydrocephalus: clinical comorbidity correlated with cerebral biopsy findings and outcome of cerebrospinal fluid shunting , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[33]  H. Topka,et al.  Broadening a classic clinical triad: The hypokinetic motor disorder of normal pressure hydrocephalus also affects the hand , 2006, Experimental Neurology.

[34]  Marvin Bergsneider,et al.  Diagnosing Idiopathic Normal-pressure Hydrocephalus , 2005, Neurosurgery.

[35]  Anthony Marmarou,et al.  Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients. , 2005, Journal of neurosurgery.

[36]  D. Yarnitsky,et al.  Cryptococcal meningitis mimicking vascular dementia , 2004, Neurology.

[37]  K. Ishii,et al.  CSF spaces in idiopathic normal pressure hydrocephalus: morphology and volumetry. , 1998, AJNR. American journal of neuroradiology.

[38]  R. D. Adams,et al.  SYMPTOMATIC OCCULT HYDROCEPHALUS WITH "NORMAL" CEREBROSPINAL-FLUID PRESSURE.A TREATABLE SYNDROME. , 1965, The New England journal of medicine.

[39]  M. Hoffmann,et al.  Cryptococcal meningitis misdiagnosed as Alzheimer's disease: complete neurological and cognitive recovery with treatment. , 2009, Journal of Alzheimer's disease : JAD.

[40]  E. Mori,et al.  Guidelines for management of idiopathic normal pressure hydrocephalus. , 2008, Neurologia medico-chirurgica.